Recent data have suggested that pediatric patients wait-listed for a liver transplantation frequently have liver offers declined. However, factors associated with liver offer decisions and center-level variability in practice patterns have not been explored. We evaluated United Network for Organ Sharing data on all match runs from May 1, 2007 to December 31, 2015 in which the liver was offered to 1 pediatric patient; the transplant recipient was ranked in the first 40 positions for the organ offer; and the donor was brain-dead and <50 years of age. We used multilevel mixed effects models to evaluate factors associated with organ offer acceptance, among-center variability, and the association between center-level acceptance and wait-list mortality. There were 4088 unique pediatric patients during the study period, comprising 27,094 match runs. Initial Model for End-Stage Liver Disease or Pediatric End-Stage Liver Disease score, history of exception points, recipient region, rank on match run, and geographic share type were all associated with probability of offer acceptance. There was significant among-center variation (P < 0.001) in adjusted liver offer acceptance rates, accounting for donor, recipient, and match-related factors (adjusted acceptance rates: median, 8.9%; range, 5.1%-14.6%). Center-level acceptance rates were associated with wait-list mortality, with a >10% increase in the risk of wait-list mortality for every 1% decrease in a center's adjusted liver offer acceptance rate (odds ratio, 1.10; 95% confidence interval, 1.01-1.19). In conclusion, there is significant among-center variability in liver offer acceptance rates for pediatric patients that is not explained by donor and recipient factors. A center's liver acceptance behavior significantly impacts whether a pediatric patient will be transplanted or die on the waiting list.
Pediatric patients wait-listed for a liver transplantation (LT) in the United States are prioritized based on their Model for End-Stage Liver Disease (MELD) or Pediatric End-Stage Liver Disease (PELD) score, depending on the patient's age. (1, 2) When a liver from a deceased donor becomes available, a list of all patients eligible for such organs is created by the United Network for Organ Sharing (UNOS), which is dependent on donor factors and recipient compatibility. The UNOS rank list is based on a patient's MELD/PELD score and his/her geographic location relative to the potential donor. When an offer for a deceased donor liver is made, the transplant physician must determine whether to accept or decline the offer for a given patient, often without discussion with the patient and/ or his/her next-of-kin due to time constraints and/or complexities of the organ offer process.
Although there are several characteristics that define the "quality" of a donor liver, a principal objective factor of donor organ quality is the donor's age. (3) When an offer is made, transplant physicians must weigh not only the "quality" of the donor liver, but also must balance this against the following factors:
1. The clinical stability of the potential recipient. 2. The likelihood the patient will receive another offer of similar quality in the near future.
3. Whether declining the offer would be advantageous for the next ranked recipient listed at the same center.
Because of the many uncertainties associated with organ offer decision making, in adult LT, there is dramatic variability in organ offer acceptance rates among transplant centers. (4) However, this phenomenon has not been explored in pediatric LT, which has additional complexities compared with adult transplantation. In pediatrics, the decision to decline a liver for a given patient not only can influence whether the patient lives or dies, but also his/her potential for impaired neuropsychological development resulting from a delay in transplantation. (5) Despite a system that prioritizes pediatric patients, there are still a significant number of children who die prior to receiving a transplant, with pediatric liver wait-list mortality rates ranging from 7% to 12%. (6) Recent data published by Hsu et al. demonstrated that half of the pediatric patients who died on the waiting list had been offered an organ that was eventually transplanted into another pediatric patient.
(7) These data did not evaluate donor-and recipient-level factors that were associated with organ acceptance, and they did not evaluate whether there was undue variability in center acceptance practices that directly would impact whether a pediatric patients lives or dies. Thus, we sought to critically evaluate data on organ offers to pediatric patients to determine the following:
1. Donor and recipient factors associated with organ offer acceptances. 2. Whether there are significant among-center differences in acceptance practices after accounting for key donor and recipient factors. 3. Whether center-level practices regarding organ offer acceptances influence patient survival.
Such data are needed if we seek to standardize acceptance practices and minimize undue variability in patient care.
Patients and Methods

US ORGAN ALLOCATION SYSTEM
Each time a deceased donor liver becomes available, UNOS creates a "match run," which is a rank order list based on the blood type of the donor and potential recipient, the potential recipient's location, and the most recent PELD or MELD score. The age of the donor also plays an important role as the algorithm prioritizes giving organs from pediatric donors to pediatric patients. The organ is then offered sequentially to patients listed on the match run. The transplant center has the option to accept or decline the offer. Common reasons to decline include donor quality, recipient clinical status, and donor recipient-size mismatch. It is important to note that although transplant center performance is closely tracked in the United States, patients who die prior to receiving a transplant are not included in these metrics.
STUDY SAMPLE
We used data from UNOS on all liver offers (match runs) where the liver was ultimately transplanted between May 1, 2007 and December 31, 2015. Organ offer data were only available for livers that were eventually transplanted.
We restricted match runs to those where the following occurred:
1. At least one pediatric (<18 years of age at the time of the match run) patient was offered the organ. 2. The organ was accepted and transplanted in a recipient ranked 1-40 on the match run (98.4% of pediatric recipients underwent transplantation at a position 40). 3. The donor was brain-dead and <50 years of age (>98% of deceased donor livers in pediatric recipients meet these criteria).
We excluded patients listed for multiple organs and patients listed at a "low-volume" transplant center, which we defined as <7 cumulative patients listed for transplant during our study period. We excluded lowvolume centers because of concern that other factors, such as availability of staff, may impact decision making, in addition to preventing biased center-level results due to small sample sizes. Institutional review board approval from the University of Pennsylvania, Philadelphia, was obtained prior to the initiation of this analysis.
COVARIATES
Key recipient covariates for organ acceptance and survival models included the following: age, sex, race/ethnicity, body surface area (BSA), calculated PELD/ MELD score, receipt of PELD/MELD exception points, etiology of liver disease, Status 1 status, history of a previous LT, encephalopathy at time of listing, and ascites at time of listing. Geographic factors included the following: number of pediatric LT centers in the local donor service area (DSA), center volume, and if the center offers living related donation. Center volume was defined by the unique number of patients who appeared on a match run and who were ranked 1-40 during the study period. Volume was categorized as <100, 100-200, and >200 patients. Donor covariates included the following: age, sex, race/ethnicity, BSA, blood type, mechanism of death, and if the donor was classified as Public Health Services (PHS) increased risk. Covariates unique to each match included the following: patient ranked position (1-4 or 5), number of offers previously received by the recipient, and organ share type (local, regional, or national).
OUTCOMES
The primary outcome was whether an organ offer was accepted or declined for a given patient. For example, if the eventual recipient was ranked fifth, then patients ranked 1-4 would be considered a "decline." In analyses evaluating among-center variability in organ offer acceptance rates, the individual offer was the unit of analysis, and data were then aggregated by center to calculate the center acceptance rate. For models assessing wait-list mortality, we used a standard outcome combining wait-list removal for death and being "too sick to transplant." (4, 7, 8) Patient survival was based on coding in the UNOS database.
STATISTICAL ANALYSIS
Center Acceptance Rates
To model the binary outcome of organ offer acceptance, multilevel logistic regression models were fit with the center as a random effect. The center was modeled as a random effect as each center is assumed to have different baseline organ acceptance rates. To further account for clustering both of patients within centers and organ offers within individual patients, the primary models were multilevel with 2 levels (center and patient). Adjusted acceptance rates were then calculated accounting for recipient, donor, and match characteristics by using the output of the multivariate model. We hypothesized that there would be no difference in acceptance rates among centers after including all covariates in the model. Multivariate models include covariates that were significant in multivariate models (P < 0.1) and/or covariates with important biological factors of interest (ie, sex, race/ ethnicity). (4) WAIT-LIST MORTALITY Wait-list mortality was modeled using logistic regression models for the binary outcome of transplanted or dying/too sick. These models evaluated the association between center acceptance patterns and wait-list mortality for an individual patient. The primary exposure was the calculated adjusted acceptance rate for the transplant center, and the outcome was wait-list mortality determined at the patient level. Patients could only contribute 1 outcome (and 1 row of data) for this model. Center-level random intercepts were included in the model in order to account for clustering within centers and DSAs.
All statistical analyses were performed using Stata, version 14.0 (Stata Corp., College Station, TX).
Results
There were 4088 unique pediatric patients who appeared on 1 match run while ranked 1-40 during the study period. This encompassed 27,094 match runs. At the time of listing, the median patient age was 1 year (interquartile range [IQR], 0-8 years), and the median calculated PELD/MELD score was 12 (IQR, 1-22; Table 1 ). Several factors were associated with an increased odds of having an organ offer accepted, including the following: higher MELD/PELD, no history of exception points, larger recipients (BSA), recipients ranked in the first 4 positions on the match run, smaller donors (BSA), and the organ distribution unit (local, regional, or national; Table 2 ).
AMONG-CENTER VARIATION IN ORGAN OFFER ACCEPTANCE
Despite adjusting for patient, donor, and match characteristics, there was significant among-center variation in organ offer acceptance rates (P < 0.001). This was not explained by the number of centers in the DSA, center volume, or having a living donor liver transplantation (LDLT) program (P > 0.20 for all 3 covariates). The adjusted among-center acceptance rates ranged from 5.1% to 14.6%, and they were different even among centers within a geographic region (Fig. 1) .
CENTER-LEVEL ORGAN OFFER ACCEPTANCE AND WAIT-LIST OUTCOME
During the study period, 204 (5.0%) patients were removed from the waiting list due to death or becoming too sick to transplant, 116 and 88 patients, respectively. Mortality was higher among patients listed as status 1 (8.7% versus 4.1%; P < 0.001). In multivariate models accounting for recipient factors, the adjusted liver acceptance rates at a center were significantly associated with a patient's individual probability of dying on the waiting list (odds ratio [OR], 1.10; 95% confidence interval [CI], 1.01-1.19; Table 3 ).
The Spearman's correlation coefficient between the adjusted center acceptance rate and unadjusted 1-year graft survival was -0.21 (P 5 0.31), indicating that there was no relationship between these 2 outcomes.
Discussion
In this analysis of more than 8 years of organ offer data, we observed an almost 3-fold difference in center-level liver offer acceptance for pediatric patients. This variation was not explained by key donor and recipient factors. The differences in decision making not only influenced the probability of transplant, but patients who were wait-listed at a center with a lower liver offer acceptance rate had a significantly increased risk of dying on the waiting list. Interestingly, centerlevel liver offer acceptance rates were not correlated with graft survival, suggesting that center selectivity did not result in improved transplant outcomes.
There was previously little known about decision making in regards to organ offers for pediatric patients. Earlier this year, Hsu et al. published that over half of the children who died prior to transplantation had previously been offered an organ that was eventually transplanted into a pediatric patient. (7) This suggested that many waitlist deaths could be prevented because transplantable organs were declined on behalf of these patients. Their study did not look at characteristics of the organ offers or differences in practice patterns between pediatric centers.
In looking at factors associated with organ offer acceptance, we found that prioritizing patients for transplant using exception points, rather than calculated MELD/PELD score, was associated with increased probability of the offer being declined. Patients who had exception points were approximately 30% more likely to have an organ rejected on their behalf although they are given these exception points because they are deemed to be sicker than their calculated MELD/PELD score reflects. Approximately 40% of pediatric patients receive exception points (data not shown). (9, 10) This finding was also seen in the adult population and may reflect that the patients receiving exception points are not necessarily sicker, which would be why centers are less likely to accept an organ offer, and thus, there is a need for a more standardized process. (4) Yet the fact that all deaths occurred in nonexception patients may also suggest that some patients in need of extra priority do not receive the needed points. We also found that the designation of status 1 was associated with decreased offer acceptance. This could be explained by the potential for these patients to be highest on multiple offers, and/or the clinician's impression that the patient may recover. Despite this, patients who were listed as status 1 had a higher mortality compared with those not given that status. This may be due to the severity and types of diseases. The lower acceptance rates in these patients and the higher mortality would suggest that changes in decision making and increased organ acceptance rates NOTE: All variables are at time of listing unless otherwise specified. Model was mixed-effects logistic regression model with individual center-level random intercepts. The P < 0.001 indicated that there was residual heterogeneity between transplant centers after accounting for the patient demographic and geographic factors in the multivariate model based on the test of random center effects. Other covariates forced into the model but not presented because they were not significant were as follows: recipient age (P 5 0.21), recipient sex (P 5 0.67), recipient race (P 5 0.39), encephalopathy (P 5 0.51), ascites (P 5 0.09), recipient blood type (P 5 0.10), number of offers previously received by recipient (P 5 0.06), number of local centers (P 5 0.95), center volume (P 5 0.23), and LDLT center (P 5 0.43).
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for these sickest patients may help to decrease wait-list mortality of pediatric patients. Many organs are potentially being turned down due to unconscious biases. Even after controlling for characteristics related to the donor, a recipient that was listed below the 4th position on the match run was less likely to have an organ accepted. Although there may be qualities about the declined organ that we were not able to capture with our model, these organs are also likely being judged as inferior because they have already been rejected. Organs that were from a PHS increased risk donor (IRD) were also significantly more likely to be declined even though IRDs are the fastest growing population of organ donors. Although there is an increase in the risk of infection, these donors are often young and otherwise healthy, and it has been shown that utilization of IRDs yields equivalent outcomes. (11) Center characteristics did not predict acceptance patterns. Because center certification is tied to transplant outcomes, there is concern that smaller centers may be more risk adverse. Although it has been demonstrated that patients at low-volume centers have a lower chance of being transplanted and are even more likely to die on the waiting list, this cannot be explained by center acceptance rates. (12) There was no correlation between acceptance rates and center volume.
There were limitations with respect to the data available in the UNOS database. Reasons for rejection of an offer for transplant are reported but are often incomplete or incorrect. (4, 8) The number of transplant surgeons and their training background (pediatric surgery versus transplant surgery) are not known. The database also does not include information on family economic status or education. We were only able to examine offers for whole organs because splitting is done at the center level and is therefore outside of the match process in the United States. There are also many nuances to the decision to perform a LT that are difficult to capture in a large database. These factors could include family preference, the clinical status of the recipient at time of organ offer, and size mismatch between the recipient and donor. However, although these factors may differ by center, the magnitude of the among-center differences is so robust that it is unlikely that unequal distribution of these factors across transplant centers would explain the results of this study.
In conclusion, there is significant variability in center acceptance patterns of offers for transplantation to pediatric patients even after accounting for donor and recipient characteristics. Being listed at a center with a low acceptance rate considerably increases a child's probability of dying prior to receiving a transplant. Although it would be infeasible to discuss every offer with the patient or family, there should be shared decision making when possible. (13) It is necessary to standardize the acceptance process so that all children have equal opportunity for transplantation. Future work should explore factors that impact decision making that cannot be discerned from the UNOS database. These data also could be considered in future transplant center benchmarking as a means to increase organ acceptance and decrease mortality of pediatric patients wait-listed for a LT.
